Discover how Human Digital Twin (HDT) technology is revolutionizing clinical decision-making. From predicting patient outcomes to enhancing precision medicine, see how Mesh Bio’s HealthVector® Diabetes platform empowers clinicians to deliver safer, faster, and more personalized care.
.png)
Managing Type 2 Diabetes goes far beyond a diagnosis—it’s a daily juggling act of monitoring, medication, diet, and lifestyle. Thankfully, Artificial Intelligence (AI) is changing the game. In this article, we explore how AI is transforming diabetes care across five key areas: early detection, personalized treatment, real-time blood sugar monitoring, digital health coaching, and clinical decision support. Plus, discover how Mesh Bio’s HealthVector® Diabetes platform leverages Human Digital Twin technology to provide predictive, data-driven insights for better outcomes.
Managing diabetes starts with understanding your HbA1c levels—a key marker of long-term blood sugar control. This blog explains what HbA1c is, how to interpret it, and shares six effective strategies to help keep your levels in check, including diet, exercise, stress management, and proper medication use. It also introduces how Mesh Bio’s HealthVector® Diabetes software supports personalized, data-driven care to prevent complications and improve outcomes.
.png)
Blood tests like fasting glucose, HbA1c, OGTT, and insulin levels can offer early warning signs of diabetes — but they don’t tell the whole story. This article explains what each test reveals, what they may miss (like daily glucose spikes, metabolic flexibility, and inflammation), and how Mesh Bio’s HealthVector® Diabetes software provides deeper, AI-powered insights to support proactive diabetes management.